Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D003630:Daunorubicin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D005470:Fluorometry; D007109:Immunity / Q000528:radiation effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007939:Leukemia L1210 / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D051379:Mice; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D011830:Radiation Effects; D013154:Spleen / Q000378:metabolism; D013950:Thymus Gland / Q000378:metabolism; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; D003630:Daunorubicin